MESOBLAST LTD
Develops off-the-shelf cellular medicines for complex inflammatory and chronic diseases.
MESO | NDAQ
Overview
Corporate Details
- ISIN(s):
- US5907171046 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- LEVEL 38, 3000 MELBOURNE, VICTORIA
- Website:
- https://www.mesoblast.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Mesoblast is a regenerative medicine company focused on developing and commercializing allogeneic (off-the-shelf) cellular medicines. The company utilizes its proprietary mesenchymal lineage cell technology platform to create innovative treatments for complex inflammatory diseases and other conditions resistant to conventional therapies. Its platform is based on cells collected from healthy adult donors, which are expanded at an industrial scale. A key feature of its product candidates is the ability to be administered without donor-recipient matching or recipient immune suppression. Mesoblast's advanced portfolio includes Phase 3 product candidates targeting steroid-refractory acute graft versus host disease (GVHD), acute respiratory distress syndrome (ARDS), advanced chronic heart failure, and chronic low back pain.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all MESOBLAST LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MESOBLAST LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MESOBLAST LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
